Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.
Press releases published on August 25, 2025
Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals
GlobeNewswire
·
August 25, 2025
“We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our internal metrics across all verticals in the first seven months of the year, reinforcing the strength of our strategy. A key focus has been our investment in making …
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team …
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
GlobeNewswire
·
August 25, 2025
- U.S. IND filing planned for Q4 2025 with U.S. enrollment expected to start in Q1 2026 - Patient dosing expected to begin in Australia in Q4 2025 HUNTSVILLE, AL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), …
Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer
GlobeNewswire
·
August 25, 2025
TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Memgen, Inc., a clinical-stage biotechnology company developing oncolytic immunotherapy for solid tumors, today announced the dosing of the first patient in its Phase 1 combination cohort evaluating …
Option Care Health To Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
BANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor …
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
GlobeNewswire
·
August 25, 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference
GlobeNewswire
·
August 25, 2025
ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in …
OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
GlobeNewswire
·
August 25, 2025
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to …
Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
GlobeNewswire
·
August 25, 2025
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, …
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
GlobeNewswire
·
August 25, 2025
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in the …
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
GlobeNewswire
·
August 25, 2025
MP0533 data presented at European Hematology Association (EHA) highlights improved response rates and antitumor activity in low disease burden patients; additional data under amended dosing scheme expected in Q4 2025 IND filing on first radio-DARPin …
Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy
GlobeNewswire
·
August 25, 2025
RIYADH, Saudi Arabia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions
GlobeNewswire
·
August 25, 2025
WARREN, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment …
Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight
GlobeNewswire
·
August 25, 2025
New York, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight Insmed’s BRINSUPRI (brensocatib) has reached a significant regulatory milestone, earning FDA …
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
GlobeNewswire
·
August 25, 2025
WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in …
Dr. Wade Newman Grant for Healthcare Students Opens Applications to Support Future Leaders in Medicine and Allied Health
GlobeNewswire
·
August 25, 2025
BELLEFONTE, Pa., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Dr. Wade Newman Grant for Healthcare Students is now officially open for applications, offering undergraduate students pursuing careers in healthcare the opportunity to gain meaningful financial …
Dr. Kevin Ciresi Scholarship for Medical Students Opens Applications for Aspiring Future Physicians
GlobeNewswire
·
August 25, 2025
DANVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Dr. Kevin Ciresi Scholarship for Medical Students officially announces the opening of its 2026 application cycle, offering undergraduate students across the United States an opportunity to pursue …
Protecting healthcare workers protects us all:
GlobeNewswire
·
August 25, 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Canadian healthcare workers deserve the same on-the-job protections as workers in every other sector — and new national standards may finally deliver them. More than 1,700 physicians, nurses, scientists, engineers …
Protéger le personnel de la santé, c’est nous protéger tous
GlobeNewswire
·
August 25, 2025
TORONTO, 25 août 2025 (GLOBE NEWSWIRE) -- Le personnel de la santé au Canada mérite les mêmes protections au travail que les employés de tous les autres secteurs, et de nouvelles normes nationales pourraient enfin les leur garantir. Plus de 1 700 médecins, …
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
GlobeNewswire
·
August 25, 2025
Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the Paradise™ Ultrasound Renal Denervation (uRDN) system has received approval for …